Wangqiu Gong

769 total citations
15 papers, 607 citations indexed

About

Wangqiu Gong is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Wangqiu Gong has authored 15 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Nephrology and 4 papers in Epidemiology. Recurrent topics in Wangqiu Gong's work include Autophagy in Disease and Therapy (3 papers), Cancer Mechanisms and Therapy (2 papers) and Parathyroid Disorders and Treatments (2 papers). Wangqiu Gong is often cited by papers focused on Autophagy in Disease and Therapy (3 papers), Cancer Mechanisms and Therapy (2 papers) and Parathyroid Disorders and Treatments (2 papers). Wangqiu Gong collaborates with scholars based in China. Wangqiu Gong's co-authors include Haibo Long, Fenfen Peng, Wenting Liu, Congwei Luo, Bohui Yin, Xiaowen Chen, Yuxian Wang, Lingzhi Sun, Hongyu Li and Chen Zhao and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and The FASEB Journal.

In The Last Decade

Wangqiu Gong

15 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wangqiu Gong China	12	366	197	120	93	63	15	607
Can Wu China	13	333 0.9×	195 1.0×	172 1.4×	121 1.3×	89 1.4×	15	710
Jia Guo China	14	233 0.6×	123 0.6×	115 1.0×	71 0.8×	60 1.0×	38	591
Yanbin Gao China	16	446 1.2×	206 1.0×	197 1.6×	94 1.0×	64 1.0×	29	788
Zhiyao Zhu China	11	432 1.2×	239 1.2×	198 1.6×	62 0.7×	55 0.9×	23	723
Suxia Yang China	16	280 0.8×	103 0.5×	118 1.0×	51 0.5×	80 1.3×	27	580
Yunpeng Chang China	10	300 0.8×	93 0.5×	187 1.6×	122 1.3×	90 1.4×	14	647
Dawei Zou China	10	404 1.1×	232 1.2×	206 1.7×	52 0.6×	46 0.7×	12	668
Guijun Qin China	19	527 1.4×	276 1.4×	167 1.4×	107 1.2×	83 1.3×	49	936
Rui Yan China	11	224 0.6×	104 0.5×	62 0.5×	56 0.6×	33 0.5×	36	446
Chengcheng Xiao China	11	331 0.9×	182 0.9×	45 0.4×	64 0.7×	41 0.7×	18	469

Countries citing papers authored by Wangqiu Gong

Since Specialization

Citations

This map shows the geographic impact of Wangqiu Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangqiu Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangqiu Gong more than expected).

Fields of papers citing papers by Wangqiu Gong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wangqiu Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangqiu Gong. The network helps show where Wangqiu Gong may publish in the future.

Co-authorship network of co-authors of Wangqiu Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Wangqiu Gong. A scholar is included among the top collaborators of Wangqiu Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wangqiu Gong. Wangqiu Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Zhong, Hai, et al.. (2023). [Management and prognosis of extremely preterm infants with gestational age ≤25⁺⁶ weeks].. PubMed. 61(1). 36–42. 1 indexed citations

Li, Yue, Wangqiu Gong, Jing Liu, et al.. (2022). Angiopoietin-like protein 4 promotes hyperlipidemia-induced renal injury by down-regulating the expression of ACTN4. Biochemical and Biophysical Research Communications. 595. 69–75. 11 indexed citations

Gong, Wangqiu, Congwei Luo, Fenfen Peng, et al.. (2021). Brahma-related gene-1 promotes tubular senescence and renal fibrosis through Wnt/β-catenin/autophagy axis. Clinical Science. 135(15). 1873–1895. 51 indexed citations

Chen, Xiaowen, Wenting Liu, Jing Xiao, et al.. (2020). FOXO3a accumulation and activation accelerate oxidative stress‐induced podocyte injury. The FASEB Journal. 34(10). 13300–13316. 26 indexed citations

Peng, Fenfen, Wangqiu Gong, Shuting Li, et al.. (2020). circRNA_010383 Acts as a Sponge for miR-135a, and Its Downregulated Expression Contributes to Renal Fibrosis in Diabetic Nephropathy. Diabetes. 70(2). 603–615. 97 indexed citations

Peng, Fenfen, Wangqiu Gong, Shu‐Ting Li, et al.. (2020). circRNA_010383 Acts as a Sponge for miR-135a and its Downregulated Expression Contributes to Renal Fibrosis in Diabetic Nephropathy. Diabetes. 70(2). db200203–db200203. 85 indexed citations

Li, Shuting, Fenfen Peng, Wangqiu Gong, et al.. (2019). Dimethylaminomicheliolide ameliorates peritoneal fibrosis through the activation of autophagy. Journal of Molecular Medicine. 97(5). 659–674. 21 indexed citations

Li, Peilin, Yuxian Wang, Shuting Li, et al.. (2019). MicroRNA-145 promotes the epithelial-mesenchymal transition in peritoneal dialysis-associated fibrosis by suppressing fibroblast growth factor 10. Journal of Biological Chemistry. 294(41). 15052–15067. 20 indexed citations

Liu, Wenting, Xiaowen Chen, Yuxian Wang, et al.. (2019). Micheliolide ameliorates diabetic kidney disease by inhibiting Mtdh-mediated renal inflammation in type 2 diabetic db/db mice. Pharmacological Research. 150. 104506–104506. 41 indexed citations

10.

Zhang, Ying, Yihua Chen, Yuxian Wang, et al.. (2019). Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway. International Immunopharmacology. 78. 106064–106064. 41 indexed citations

11.

Peng, Fenfen, Hongyu Li, Shuting Li, et al.. (2019). Micheliolide ameliorates renal fibrosis by suppressing the Mtdh/BMP/MAPK pathway. Laboratory Investigation. 99(8). 1092–1106. 30 indexed citations

12.

Gong, Wangqiu, Jing Chen, Chunxi Huang, et al.. (2018). Micheliolide alleviates hepatic steatosis in db/db mice by inhibiting inflammation and promoting autophagy via PPAR-γ-mediated NF-кB and AMPK/mTOR signaling. International Immunopharmacology. 59. 197–208. 57 indexed citations

13.

Huang, Wei‐Chang, et al.. (2016). [Irbesartan ameliorates cardiac inflammation in type 2 diabetic db/db mice].. PubMed. 37(4). 505–511. 4 indexed citations

14.

Liu, Wenting, Fenfen Peng, Hongyu Li, et al.. (2016). Metadherin facilitates podocyte apoptosis in diabetic nephropathy. Cell Death and Disease. 7(11). e2477–e2477. 62 indexed citations

15.

Gong, Wangqiu, Lu Lu, Jing Chen, et al.. (2016). Irbesartan ameliorates hyperlipidemia and liver steatosis in type 2 diabetic db/db mice via stimulating PPAR-γ, AMPK/Akt/mTOR signaling and autophagy. International Immunopharmacology. 42. 176–184. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact